Atlas Trials

A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet

Clinical trial NCT01454544 · COMPLETED

Trial details

NCT number
NCT01454544
Sponsor
ALK-Abelló A/S
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
House Dust Mite Allergy
Start date
2011-10-01
Primary completion
2013-04-01
Enrollment
992

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.